Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844What this trial is testingBreast Cancer Study of Preoperative Pembrolizumab + RadiationWho this might be right forBreast Cancer Stephen Shiao 66
Not applicableStudy completedNCT03030404What this trial is testingHereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerWho this might be right forStomach NeoplasmsStomach CancerGastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)+2 more National Cancer Institute (NCI) 733
Early research (Phase 1)Study completedNCT02658214What this trial is testingDurvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsWho this might be right forSmall Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more AstraZeneca 32
Testing effectiveness (Phase 2)Ended earlyNCT02127073What this trial is testingPilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast CancerWho this might be right forBreast CancerDuctal Carcinoma in Situ Montefiore Medical Center 8
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Not applicableStudy completedNCT05227261What this trial is testingEarly Detection of Five Common Cancers Using the ctDNA Analysing TestWho this might be right forCancer, LungCancer, BreastCancer Liver+4 more Gene Solutions 9,057
Early research (Phase 1)Study completedNCT00005886What this trial is testingTamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast CancerWho this might be right forBreast Cancer University of Kansas Medical Center
Testing effectiveness (Phase 2)Study completedNCT03241173What this trial is testingA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced Malignancies Incyte Biosciences International Sàrl 52
Not applicableStudy completedNCT00602628What this trial is testingRadiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastWho this might be right forBreast Cancer Royal Marsden NHS Foundation Trust 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267What this trial is testingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Who this might be right forBreast CancerCholangiocarcinomaColorectal Cancer+13 more Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Study completedNCT05253053What this trial is testingTo Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more TransThera Sciences (Nanjing), Inc. 84
Testing effectiveness (Phase 2)Study completedNCT02983045What this trial is testingA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsWho this might be right forMelanomaRenal Cell CarcinomaNon Small Cell Lung Cancer+4 more Nektar Therapeutics 557
Early research (Phase 1)Ended earlyNCT05194072What this trial is testingFelmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsWho this might be right forOvarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms+8 more Seagen, a wholly owned subsidiary of Pfizer 250
Not applicableStudy completedNCT02766881What this trial is testingEvaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCISWho this might be right forDCIS Ontario Clinical Oncology Group (OCOG) 281
Early research (Phase 1)Study completedNCT01770353What this trial is testingMM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentWho this might be right forSolid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more Ipsen 45
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037What this trial is testingTamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerWho this might be right forBreast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Study completedNCT00290745What this trial is testingTamoxifen or Letrozole in Treating Women With Ductal Carcinoma in SituWho this might be right forBreast Cancer University of California, San Francisco 79
Early research (Phase 1)Study completedNCT00788112What this trial is testingVorinostat in Treating Women With Ductal Carcinoma in Situ of the BreastWho this might be right forBreast Cancer University of California, San Francisco 17
Early research (Phase 1)Active Not RecruitingNCT05394259What this trial is testingA Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerWho this might be right forPancreatic CancerBreast CancerHepatocellular Carcinoma M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00417495What this trial is testingSentinel Lymph Node Technique in Multifocal Breast CancerWho this might be right forBreast Cancer Centre Oscar Lambret 216